Quidel Corporation (NASDAQ:QDEL) SVP Robert Joseph Bujarski sold 110,704 shares of the company’s stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $39.78, for a total transaction of $4,403,805.12. Following the transaction, the senior vice president now owns 79,797 shares in the company, valued at approximately $3,174,324.66. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of Quidel Corporation (QDEL) traded down $0.15 during mid-day trading on Friday, reaching $40.00. The company’s stock had a trading volume of 651,002 shares, compared to its average volume of 416,164. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.68 and a current ratio of 6.28. Quidel Corporation has a 12 month low of $18.25 and a 12 month high of $45.55.
Quidel (NASDAQ:QDEL) last announced its quarterly earnings data on Wednesday, November 1st. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.21). The firm had revenue of $50.89 million during the quarter, compared to analysts’ expectations of $50.47 million. Quidel had a negative net margin of 2.33% and a negative return on equity of 2.36%. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.10 EPS. sell-side analysts expect that Quidel Corporation will post 0.6 EPS for the current year.
A number of hedge funds have recently made changes to their positions in the business. TIAA CREF Investment Management LLC increased its stake in shares of Quidel by 1.1% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 99,227 shares of the company’s stock worth $2,693,000 after acquiring an additional 1,062 shares during the last quarter. SG Americas Securities LLC increased its stake in shares of Quidel by 8.1% in the 2nd quarter. SG Americas Securities LLC now owns 38,347 shares of the company’s stock worth $1,041,000 after acquiring an additional 2,871 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of Quidel by 45.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 174,788 shares of the company’s stock worth $4,744,000 after acquiring an additional 54,206 shares during the last quarter. Swiss National Bank increased its stake in shares of Quidel by 4.2% in the 3rd quarter. Swiss National Bank now owns 47,200 shares of the company’s stock worth $2,070,000 after acquiring an additional 1,900 shares during the last quarter. Finally, Harvest Management LLC acquired a new stake in shares of Quidel in the 3rd quarter worth $702,000. Institutional investors own 92.67% of the company’s stock.
Several equities analysts have recently issued reports on the stock. Raymond James Financial restated a “buy” rating and set a $47.00 price objective (up previously from $41.00) on shares of Quidel in a report on Tuesday, September 19th. Piper Jaffray Companies upgraded shares of Quidel from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $35.00 to $50.00 in a report on Tuesday, September 19th. Zacks Investment Research upgraded shares of Quidel from a “strong sell” rating to a “hold” rating in a report on Wednesday, September 27th. Canaccord Genuity reiterated a “buy” rating and issued a $48.00 price target (up previously from $42.00) on shares of Quidel in a report on Tuesday, September 19th. Finally, Barclays reiterated a “buy” rating and issued a $45.00 price target (up previously from $39.00) on shares of Quidel in a report on Tuesday, September 19th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $48.80.
TRADEMARK VIOLATION WARNING: “Quidel Corporation (QDEL) SVP Robert Joseph Bujarski Sells 110,704 Shares of Stock” was published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://transcriptdaily.com/2017/12/16/quidel-corporation-qdel-svp-robert-joseph-bujarski-sells-110704-shares-of-stock.html.
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.
Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.